Comparison of Results Obtained in the 145 Patients Eligible for the Study and in the Total Population of Subjects That Were Recruited and Treated
Patients . | Response . | Deaths . | Survival . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TM . | OS . | RFS . | FFS . | ||||||||
CR . | PR . | 3 yr . | 5 yr . | 3 yr . | 5 yr . | 3 yr . | 5 yr . | 3 yr . | 5 yr . | ||
Eligible (145) | 0.944 | 0.028 | 0.124 | 0.915 | 0.889 | 0.908 | 0.881 | 0.833 | 0.814 | 0.845 | 0.786 |
All treated (155) | 0.935 | 0.032 | 0.135 | 0.902 | 0.878 | 0.896 | 0.872 | 0.838 | 0.820 | 0.838 | 0.785 |
Patients . | Response . | Deaths . | Survival . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TM . | OS . | RFS . | FFS . | ||||||||
CR . | PR . | 3 yr . | 5 yr . | 3 yr . | 5 yr . | 3 yr . | 5 yr . | 3 yr . | 5 yr . | ||
Eligible (145) | 0.944 | 0.028 | 0.124 | 0.915 | 0.889 | 0.908 | 0.881 | 0.833 | 0.814 | 0.845 | 0.786 |
All treated (155) | 0.935 | 0.032 | 0.135 | 0.902 | 0.878 | 0.896 | 0.872 | 0.838 | 0.820 | 0.838 | 0.785 |